Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response

Mariette I. E. van Poelgeest, Marij J. P. Welters, Renee Vermeij, Linda F. M. Stynenbosch, Nikki M. Loof, Dorien M. A. Berends-van der Meer, Margriet J. G. Lowik, Ineke L. E. Hamming, Edith M. G. van Esch, Bart W. J. Hellebrekers, Marc van Beurden, Henk W. Schreuder, Marjolein J. Kagie, J. Baptist M. Z. Trimbos, Lorraine M. Fathers, Toos Daemen, Harry Hollema, A. Rob P. M. Valentijn, Jaap Oostendorp, Hanneke N. G. Oude ElberinkGertjan J. Fleuren, Tjalling Bosse, Gemma G. Kenter, Theo Stijnen, Hans W. Nijman, Cornelis J. M. Melief, Sjoerd H. van der Burg

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2342-2350
JournalClinical Cancer Research
Volume22
Issue number10
DOIs
Publication statusPublished - 15 May 2016

Cite this

van Poelgeest, M. I. E., Welters, M. J. P., Vermeij, R., Stynenbosch, L. F. M., Loof, N. M., Berends-van der Meer, D. M. A., ... van der Burg, S. H. (2016). Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response. Clinical Cancer Research, 22(10), 2342-2350. https://doi.org/10.1158/1078-0432.CCR-15-2594